NRC

Business Context and Reporting Period

Company: National Research Corporation (NRC Health)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2000
Business Overview: The Company provides research services, primarily in the healthcare sector. During the period, the Company completed the acquisition and renovation of a new corporate headquarters, moving into the facility in October 2000.

Key Financial Metrics

Note: Working Capital calculated as Total Current Assets ($14,111,194) minus Total Current Liabilities ($6,270,941). Total Debt includes Construction financing line of credit ($260,000), Current portion of long-term debt ($132,284), and Long-term debt ($5,331,432).

Material Changes vs. Prior Period

• Revenue Trends: Revenue decreased 10.4% in the third quarter compared to the prior year ($5.0M vs $5.6M) due to the completion of a large backlog in late 1999. However, for the nine-month period, revenue increased 4.0% ($14.1M vs $13.6M) driven by new client additions.
• Profitability Improvement: Net income for the nine months ended September 30, 2000, more than doubled to $1.98M from $850k in the prior year. Operating margins expanded significantly from 7.0% to 16.5% for the nine-month period.
• Expense Management: Direct expenses decreased 14.5% year-over-year for the nine-month period, primarily due to technology investments reducing labor, payroll, and software conversion costs. Selling, general, and administrative (SG&A) expenses remained relatively flat as a percentage of revenue.
• Depreciation Increase: Depreciation and amortization expenses increased 73.1% for the nine-month period due to additional amortization of software and computer equipment.
• Liquidity Position: Cash and cash equivalents increased significantly to $4.9M from $1.1M at the end of the prior year period. Net cash provided by operating activities decreased to $1.7M from $3.9M, attributed to the timing of receivables collections and project billings.

Guidance, Outlook, and Risks

• Capital Expenditures: The Company plans to spend an additional $400,000 in the remainder of 2000 to renovate the new headquarters. The building was placed in service subsequent to September 30, 2000.
• Debt Refinancing: On November 10, 2000, the Company refinanced $5.4 million of its construction line of credit into a long-term note payable secured by a first mortgage on the new headquarters, bearing interest at 8.25%.
• Revenue Recognition: The Company bills clients in advance of project completion. As of September 30, 2000, deferred revenues were $2.1M and unbilled revenues were $1.3M. Substantially all of these amounts are expected to be earned within 12 months.
• Stock Repurchases: The Company has an authorization to repurchase shares. As of October 31, 2000, 53,700 shares had been repurchased under the new authorization.
• Accounting Changes: The adoption of SFAS 133 (Derivatives) and SAB No. 101 (Revenue Recognition) is not expected to have a significant effect on financial reporting.

Investor Verification Checklist

• Debt Structure: Verify the terms of the $5.4 million long-term note refinanced in November 2000 and its impact on future interest expenses.
• Revenue Sustainability: Assess whether the 4.0% nine-month revenue growth is sustainable given the 10.4% decline in the third quarter.
• Capital Expenditure Completion: Confirm the final cost of the new headquarters renovation and the timeline for full operational capacity.
• Cash Flow Timing: Monitor the timing of accounts receivable collections to ensure operating cash flow stabilizes.
• Deferred Revenue: Track the conversion of the $2.1 million in deferred revenue and $1.3 million in unbilled revenue into recognized income in the fourth quarter.